# Jinyu Bio-technology

FMD and ASF vaccines — Cell-suspension culture.

Source: https://cn.bioecon.ru/companies/jinyu-bio/
Updated: 2026-06-25

- 国家: China

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | 1.255 billion元人民币 (2024-12-31) | https://file.finance.qq.com/finance/hs/pdf/2025/04/25/1223274656.PDF |
| 产能 | 每年生产2.7 billion毫升(mL)FMD疫苗 | http://jinyubiotech.com/science/vaccines.html |
| 产能 | 每年生产口蹄疫疫苗20亿剂 | https://jinyubiotech.com/ |
| 生产基地 | 金宇保灵、扬州优邦及辽宁益康生产基地 | https://file.finance.qq.com/finance/hs/pdf/2025/04/25/1223274643.PDF |
| 生产基地 | 研究设施位于美国堪萨斯州 | https://www.pharmaceutical-technology.com/projects/jinyu-bio-technology-research-facility-kansas/ |
| 认证 | 兽药GMP认证(2021年) | https://static.sse.com.cn/stock/disclosure/announcement/c/202311/600201_20231114_CR20.pdf |
| 监管批准 | 49项新兽药注册证书及106项兽药生产批件 | https://static.sse.com.cn/stock/disclosure/announcement/c/202311/600201_20231114_CR20.pdf |
| 监管批准 | 猫传染性腹膜炎(FIP)mRNA疫苗临床试验获批 (2025-07-25) | https://news.futunn.com/en/post/59645909/major-breakthrough-in-treating-pet-incurable-diseases-first-domestic-mrna |
| 总部 | 中国内蒙古呼和浩特市 | https://www.pharnexcloud.com/data/qynb_e798cf2d2cebb25b3ea51061bc003f14.html |

独立来源: file.finance.qq.com, news.futunn.com, pharmaceutical-technology.com, pharnexcloud.com, static.sse.com.cn

## 技术

- [兽医生物技术与 mRNA 兽药](https://cn.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)